AKT1 and metabolic dysfunction-associated steatohepatitis: Lycium barbarum polysaccharides (LBPs) shield towards nonalcoholic steatohepatitis (NASH)-implicated liver damage, and LBPs counteract liver PI3K/Akt repression.